HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Conditions
- Interventions
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-11-27
- Target Recruit Count
- 190
- Registration Number
- NCT06001385
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸Colorado Blood Cancer Institute at Presbyterian St. Luke's, Denver, Colorado, United States
🇺🇸City of Hope, Duarte, California, United States
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 1000
- Registration Number
- NCT05224661
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Stanford University, Stanford, California, United States
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2023-05-03
- Target Recruit Count
- 99999999
- Registration Number
- NCT04920474
- Locations
- 🇺🇸
NMDP Biorepository, New Brighton, Minnesota, United States
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
- Conditions
- Interventions
- Drug: BusulfanRadiation: Total-body irradiationDrug: MelphalanDrug: CyclophosphamideDrug: FludarabineProcedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)Procedure: Bone Marrow Hematopoietic Stem Cell TransplantationDrug: Post-transplant CyclophosphamideDrug: MesnaDrug: TacrolimusDrug: Mycophenolate MofetilOther: Patient-Reported Outcomes
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2024-05-23
- Target Recruit Count
- 300
- Registration Number
- NCT04904588
- Locations
- 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸Ohio State Medical Center, James Cancer Center, Columbus, Ohio, United States
🇺🇸City of Hope National Medical Center, Duarte, California, United States
Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)
- Conditions
- Interventions
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2024-02-06
- Target Recruit Count
- 1229
- Registration Number
- NCT03992352
- Locations
- 🇺🇸
UMass Memorial Medical Center, Worcester, Massachusetts, United States
🇺🇸The Ohio State Universtiy, Columbus, Ohio, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2024-05-30
- Target Recruit Count
- 52
- Registration Number
- NCT03971799
- Locations
- 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸Children's Hospital of Colorado, Aurora, Colorado, United States
🇺🇸National Cancer Institute - NIH, Bethesda, Maryland, United States
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Conditions
- Interventions
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 1753
- Registration Number
- NCT03904134
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors
- Conditions
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2023-12-06
- Target Recruit Count
- 754
- Registration Number
- NCT03718546
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸Children's Health (formerly Children's Medical Center Dallas), Dallas, Texas, United States
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2020-12-02
- Target Recruit Count
- 92
- Registration Number
- NCT03558386
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population
- Conditions
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2020-07-15
- Target Recruit Count
- 19
- Registration Number
- NCT03434808